Biohaven Ltd.BHVNNYSE
Loading
Year-over-year research & development expense growth
Percentile
P29
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -13.62% |
| Q3 2025 | -23.43% |
| Q2 2025 | -1.71% |
| Q1 2025 | 12.01% |
| Q4 2024 | 6.26% |
| Q3 2024 | -49.94% |
| Q2 2024 | 101.84% |
| Q1 2024 | 15.70% |
| Q4 2023 | 41.14% |
| Q3 2023 | 20.16% |
| Q2 2023 | 25.26% |
| Q1 2023 | -53.69% |
| Q4 2022 | 159.33% |
| Q3 2022 | -70.16% |
| Q2 2022 | 152.63% |
| Q1 2022 | 67.62% |
| Q4 2021 | -10.97% |
| Q3 2021 | -39.33% |
| Q2 2021 | 67.06% |
| Q1 2021 | -36.91% |
| Q4 2020 | 28.78% |
| Q3 2020 | 34.46% |
| Q2 2020 | -24.34% |
| Q1 2020 | -15.07% |
| Q4 2019 | 7.05% |
| Q3 2019 | -64.95% |
| Q2 2019 | 329.18% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 63.02% |
| Q2 2018 | -61.56% |
| Q1 2018 | 13.22% |
| Q4 2017 | 90.75% |
| Q3 2017 | 66.50% |
| Q2 2017 | 95.71% |
| Q1 2017 | 0.00% |